发明名称 OXAZOLIDINES AS 5-HT2A ANTAGONIST
摘要 PROBLEM TO BE SOLVED: To provide compounds which act as 5-HT<SB>2A</SB>antagonists, control sequelae of apoplexy and cerebral ischemia, and are effective in treating obsessive compulsive disorders (OCD), anxiety disorders, panic attacks, depression, psychosis, schizophrenia and Parkinson's disease. SOLUTION: New oxazolidine derivatives are represented by formula (I) [wherein R<SP>1</SP>is H, CN, Hal or OA; R<SP>2</SP>and R<SP>3</SP>are each independently H, CN, Hal or OA, and may jointly form methylenedioxy; A is H, CF<SB>3</SB>or 1-6C alkyl; and Hal is F, Cl, Br or I]. COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2009256363(A) 申请公布日期 2009.11.05
申请号 JP20090149274 申请日期 2009.06.24
申请人 MERCK PATENT GMBH 发明人 BOETTCHER HENNING;PRUECHER HELMUT;GREINER HELMUT;BARTOSZYK GERD;SEYFRIED CHRISTOPH
分类号 C07D413/14;A61K31/4525;A61K31/454;A61P1/14;A61P3/04;A61P9/10;A61P9/12;A61P15/10;A61P25/00;A61P25/06;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/36;A61P43/00;C07D209/00;C07D263/00;C07D295/00;C07D491/056 主分类号 C07D413/14
代理机构 代理人
主权项
地址